Flow Cytometry
What We Do
We combine our capabilities with those of our partners to:
- Use induced pluripotent stem cells (iPSCs) and iPSC-derived neurons to study the molecular basis of neurological diseases
- Develop new tools and technology in disease modelling and target engagement that will help to identify potential therapies
- Translate newly developed assays onto an automated high-throughput platform that can be integrated with preclinical drug screens
C-BIGxEDDU
Watch our video with Nicolas Ferry, from the Clinical Biospecimen Imaging and Genetic Repository (C-BIG), and Taylor Goldsmith from The Neuro's EDDU (Early Drug Discovery Unit) and learn how we are collaborating to accelerate the discovery of new treatments for neurological disorders benefiting patients worldwide.
